MSRPS
ACAD icon

Maryland State Retirement & Pension System’s Acadia Pharmaceuticals ACAD Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
18,519
+233
+1% +$5.13K 0.01% 995
2026
Q1 		$407K Hold
18,286
– – 0.01% 953
2025
Q4 		$488K Buy
18,286
+241
+1% +$5.76K 0.01% 837
2025
Q3 		$385K Sell
18,045
-18,352
-50% -$434K 0.01% 957
2025
Q2 		$785K Buy
36,397
+476
+1% +$8.85K 0.02% 703
2025
Q1 		$597K Buy
+35,921
New +$653K 0.01% 813
2021
Q2 		– Sell
-8,800
Closed -$227K – 930
2021
Q1 		$227K Buy
+8,800
New +$387K 0.01% 945

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Maryland State Retirement & Pension System's ACAD Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Acadia Pharmaceuticals (ACAD) stake by 1.3% in Q2 2026, buying an estimated $5.13K and bringing the position to 18,519 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #995.

Maryland State Retirement & Pension System first reported a position in ACAD in Q1 2021 and has held it in 7 quarters since. The position peaked at $785K in Q2 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Maryland State Retirement & Pension System held 18,519 shares of Acadia Pharmaceuticals worth $469K as of Q2 2026.
  • Maryland State Retirement & Pension System bought 233 Acadia Pharmaceuticals shares in Q2 2026, an estimated $5.13K.
  • Acadia Pharmaceuticals made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #995 holding.
  • Maryland State Retirement & Pension System first reported a position in Acadia Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • Maryland State Retirement & Pension System's Acadia Pharmaceuticals position peaked at $785K in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.